Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Gains from Sales and Divestitures (2023 - 2024)

Historic Gains from Sales and Divestitures for Kezar Life Sciences (KZR) over the last 2 years, with Q3 2024 value amounting to $9702.0.

  • Kezar Life Sciences' Gains from Sales and Divestitures fell 9225.01% to $9702.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $9702.0, marking a year-over-year decrease of 9225.01%. This contributed to the annual value of $125188.0 for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q3 2024, Kezar Life Sciences' Gains from Sales and Divestitures is $9702.0, which was down 9225.01% from $22282.0 recorded in Q2 2024.
  • In the past 5 years, Kezar Life Sciences' Gains from Sales and Divestitures registered a high of $125188.0 during Q3 2023, and its lowest value of $9702.0 during Q3 2024.